MDxHealth SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by MDxHealth SA for the month of August 2025. The filing, dated August 5, 2025, serves to furnish a press release issued by the Company on the same date. The registrant is headquartered in Herstal, Belgium, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document acts solely as a cover sheet to transmit a press release (Exhibit 99.1) and does not contain embedded financial tables or statements.
Material Changes
No material changes versus the prior comparable period are detailed within the text of this Form 6-K. The document references an attached press release for specific updates but does not summarize those changes itself.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It explicitly states that the information in the attached press release is furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference except as expressly set forth.
Key Facts for Investor Verification
- The filing is a procedural cover for a press release dated August 5, 2025, which is attached as Exhibit 99.1.
- Financial data and operational updates are contained within the attached press release, not in the body of this Form 6-K.
- The press release information is not deemed "filed" under Section 18 of the Exchange Act, limiting its legal liability status compared to standard filings.
- Michael McGarrity, Chief Executive Officer, signed the report on behalf of the registrant.